nuroflux™ technology has been developed with key opinion leaders in stroke and biomedical engineers.
The nuroflux™ device utilises a proprietary multi-modal system to provide simultaneous monitoring of brain activity (via electroencephalography) and brain blood flow (via a novel electrocardiography-based metric).
Feasibility study detailing our novel electrocardiography-based metric in healthy volunteers:
https://link.springer.com/article/10.1007/s13534-023-00265-z
Clinical safety study in ischemic stroke patients:
https://www.tandfonline.com/doi/full/10.1080/03091902.2024.2409115#abstract
Multiple modalities allow for rich datasets, deep-learning analysis and the creation of predictive models.